Sigilon Therapeutics, Inc. - 82657L107

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Description is not available for this instrument yet.

Quarter snapshot

Latest / Compare
Q1 2023 · Q4 2022
Value (USD)
Total reported value ($000)
$4.264M
QoQ value delta ($000)
+$2.738M (+179.42%)
Implied price effect (QoQ)
+166.95%
Shares
Total shares
4,594,521
QoQ shares delta
+205,017 (+4.67%)
Total shares held by funds (by quarter)

Top holders (Q1 2023)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
CANADA PENSION PLAN INVESTMENT BOARD 1,381 1,485,185 0.0%
FMR LLC 980 1,054,600 0.0%
STATE OF WISCONSIN INVESTMENT BOARD 474 509,629 0.0%
VANGUARD GROUP INC 279 300,912 0.0%
MILLENNIUM MANAGEMENT LLC 259 278,520 0.0%
MORGAN STANLEY 229 246,829 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 148 159,900 0.0%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 116 125,000 0.0%
RENAISSANCE TECHNOLOGIES LLC 90 96,732 0.0%
GEODE CAPITAL MANAGEMENT, LLC 89 96,499 0.0%
Choate Investment Advisors 62 66,666 0.0%
STATE STREET CORP 38 41,300 0.0%
JANE STREET GROUP, LLC 29 31,542 0.0%
GOLDMAN SACHS GROUP INC 26 28,598 0.0%
NORTHERN TRUST CORP 22 24,089 0.0%
Tower Research Capital LLC (TRC) 12 13,417 0.0%
CITADEL ADVISORS LLC 10 11,100 0.0%
PRUDENTIAL FINANCIAL INC 9 10,600 0.01%
BANK OF AMERICA CORP /DE/ 8 8,872 0.0%
BARCLAYS PLC 2 2,343 0.0%
FEDERATED HERMES, INC. 1 1,277 0.0%
WELLS FARGO & COMPANY/MN 0 103 0.0%
UBS Group AG 0 708 0.0%
ADVISOR GROUP HOLDINGS, INC. 0 100 0.0%